| J0897 | Injection, denosumab, 1 mg | 20,640 | $20 | $371.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 32,650 | $10 | $326.5K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,150 | $30 | $243.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 40,200 | $1 | $160.8K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 12,810 | $10 | $102.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,120 | $20 | $98.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,040 | $90 | $96.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 420 | $110 | $43.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 670 | $60 | $38K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 240 | $130 | $30.7K |